Ventyx Biosciences Inc — Cash Flow (NASDAQ:VTYX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 38.65 M98.77 M166.52 M130.87 M 87.75 M Cash from investing activities 214.37 M74.93 M100.94 M15.51 M 79.66 M Cash from financing activities 323.55 M167.77 M53.33 M122.11 M — Free cash flow 38.39 M98.5 M166.01 M130.63 M 87.64 M

News

Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance

Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger

Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens

Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

Eli Lilly Stock Broke Out Following Plan To Acquire Ventyx Biosciences

Stock Market Rallies Broadly To Highs; Nvidia, AMD, Bloom Energy In Focus: Weekly Review

Healthcare dealmakers head to San Francisco hoping for megamergers in 2026

Biotech Stocks' Dark Winter Is Over. What That Means For Investors.

Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal - TipRanks.com

Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1?

Lilly to acquire Ventyx Biosciences stock for $14 per share